| |
| |
|
| Insider
Information: |
Lussow Alexander R |
| Relationship: |
Sr. VP, Bus. Dev. & Co... |
| City: |
Vancouver |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
20,000 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,040 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
20,000 |
|
|
| Total
Value |
$14,040 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novelion Therapeutics Inc |
NVLN |
Sr. VP, Bus. Dev. & Co... |
2013-05-03 |
20,000 |
2009-02-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2013-05-03 |
4 |
S |
$7.85 |
$706,500 |
D/D |
(90,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2013-05-03 |
4 |
OE |
$7.14 |
$642,600 |
D/D |
90,000 |
110,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-28 |
4 |
S |
$7.51 |
$375,315 |
D/D |
(50,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-28 |
4 |
OE |
$3.75 |
$187,500 |
D/D |
50,000 |
70,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-27 |
4 |
OE |
$2.45 |
$749,000 |
D/D |
180,000 |
200,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-27 |
4 |
S |
$7.53 |
$1,354,734 |
D/D |
(180,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-12 |
4 |
AS |
$8.02 |
$40,100 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-12-12 |
4 |
OE |
$3.79 |
$18,950 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-28 |
4 |
AS |
$7.88 |
$39,400 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-28 |
4 |
OE |
$3.76 |
$18,800 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-20 |
4 |
OE |
$3.74 |
$18,700 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-20 |
4 |
AS |
$7.81 |
$39,050 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-01 |
4 |
AS |
$7.52 |
$37,600 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-11-01 |
4 |
OE |
$3.74 |
$18,700 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-10-22 |
4 |
AS |
$7.72 |
$38,600 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-10-22 |
4 |
OE |
$3.75 |
$18,750 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-10-05 |
4 |
AS |
$7.72 |
$38,600 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-10-05 |
4 |
OE |
$3.82 |
$19,100 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-09-18 |
4 |
AS |
$7.57 |
$37,850 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-09-18 |
4 |
OE |
$3.83 |
$19,150 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-09-05 |
4 |
AS |
$7.55 |
$37,750 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-09-05 |
4 |
OE |
$3.77 |
$18,850 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-08-20 |
4 |
AS |
$7.67 |
$38,350 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-08-20 |
4 |
OE |
$3.77 |
$18,858 |
D/D |
5,000 |
25,000 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
Sr. VP, Bus. Dev. & Comm. Op. |
• – – |
2012-08-08 |
4 |
AS |
$7.92 |
$39,600 |
D/D |
(5,000) |
20,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
